{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:22:52Z","timestamp":1769167372843,"version":"3.49.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2011,3,1]],"date-time":"2011-03-01T00:00:00Z","timestamp":1298937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AI31105"],"award-info":[{"award-number":["AI31105"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1016\/j.molimm.2010.12.019","type":"journal-article","created":{"date-parts":[[2011,1,27]],"date-time":"2011-01-27T09:24:11Z","timestamp":1296120251000},"page":"883-894","source":"Crossref","is-referenced-by-count":16,"title":["Human complement receptor type 2 (CR2\/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists"],"prefix":"10.1016","volume":"48","author":[{"given":"Liudmila","family":"Kulik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte T.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. Michael","family":"Holers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2010.12.019_bib0005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0065-2776(08)60654-9","article-title":"Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21)","volume":"46","author":"Ahearn","year":"1989","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4049\/jimmunol.177.1.383","article-title":"Characterization of human complement receptor type 2 (CR2\/CD21) as a receptor for IFN-alpha: a potential role in systemic lupus erythematosus","volume":"177","author":"Asokan","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0015","doi-asserted-by":"crossref","first-page":"5806","DOI":"10.4049\/jimmunol.152.12.5806","article-title":"CD23 interacts with a new functional extracytoplasmic domain involving N-linked oligosaccharides on CD21","volume":"152","author":"Aubry","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0020","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/358505a0","article-title":"CD21 is a ligand for CD23 and regulates IgE production","volume":"358","author":"Aubry","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2010.12.019_bib0025","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1084\/jem.20021110","article-title":"B lymphocyte memory: role of stromal cell complement and FcgammaRIIB receptors","volume":"196","author":"Barrington","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2010.12.019_bib0030","doi-asserted-by":"crossref","first-page":"14490","DOI":"10.1073\/pnas.0903477106","article-title":"Uncoupling CD21 and CD19 of the B-cell coreceptor","volume":"106","author":"Barrington","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.molimm.2010.12.019_bib0035","doi-asserted-by":"crossref","first-page":"6974","DOI":"10.4049\/jimmunol.174.11.6974","article-title":"B cells from mice prematurely expressing human complement receptor type 2 are unresponsive to T-dependent antigens","volume":"174","author":"Birrell","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0040","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S1074-7613(01)00228-X","article-title":"Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein","volume":"15","author":"Boackle","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.molimm.2010.12.019_bib0045","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.4049\/jimmunol.161.12.6537","article-title":"Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells","volume":"161","author":"Boackle","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4049\/jimmunol.162.1.136","article-title":"Signaling through the EBV\/C3d receptor (CR2, CD21) in human B lymphocytes: activation of phosphatidylinositol 3-kinase via a CD19-independent pathway","volume":"162","author":"Bouillie","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0055","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.4049\/jimmunol.149.9.2841","article-title":"The CD19\/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules","volume":"149","author":"Bradbury","year":"1992","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0060","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1128\/JVI.01421-05","article-title":"Optimal long-term humoral responses to replication-defective herpes simplex virus require CD21\/CD35 complement receptor expression on stromal cells","volume":"80","author":"Brockman","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0065","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/intimm\/dxh350","article-title":"Lack of induced co-stimulation as a result of complement receptor 2 (CR2) ligation on mouse splenic B cells","volume":"18","author":"Brown","year":"2006","journal-title":"Int. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0070","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1084\/jem.186.11.1897","article-title":"Qualitative regulation of B cell antigen receptor signaling by CD19: selective requirement for P13-kinase activation, inositol-1,4,5-trisphosphate production and Ca2+ mobilization","volume":"186","author":"Buhl","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2010.12.019_bib0075","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1365-3083.2009.02274.x","article-title":"Impaired antibody responses but normal proliferation of specific CD4+ T cells in mice lacking complement receptors 1 and 2","volume":"70","author":"Carlsson","year":"2009","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0065-2776(08)60908-6","article-title":"The role of complement in B cell activation and tolerance","volume":"74","author":"Carroll","year":"2000","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0085","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/smim.1998.0120","article-title":"CD21\/CD35 in B cell activation","volume":"10","author":"Carroll","year":"1998","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0090","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1146\/annurev.immunol.16.1.545","article-title":"The role of complement and complement receptors in the induction and regulation of immunity","volume":"16","author":"Carroll","year":"1998","journal-title":"Ann. Rev. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0095","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/intimm\/14.2.139","article-title":"Depletion of Lyn kinase from the BCR complex and inhibition of B cell activation by excess CD21 ligation","volume":"14","author":"Chakravarty","year":"2002","journal-title":"Intl. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0100","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.4049\/jimmunol.164.9.4522","article-title":"Humoral immune responses in Cr2\u2212\/\u2212 mice: enhanced affinity maturation but impaired antibody persistence","volume":"164","author":"Chen","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0105","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1471-4906(03)00119-4","article-title":"Transitional B cells: step by step towards immune competence","volume":"24","author":"Chung","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0110","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1146\/annurev.iy.06.040188.000505","article-title":"Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment","volume":"6","author":"Cooper","year":"1988","journal-title":"Ann. Rev. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0115","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/j.1460-2075.1991.tb08025.x","article-title":"Epstein-Barr virus\/complement C3d receptor is an interferon-\u03b1 receptor","volume":"10","author":"Delcayre","year":"1991","journal-title":"EMBO J."},{"key":"10.1016\/j.molimm.2010.12.019_bib0120","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1126\/science.271.5247.348","article-title":"C3d of complement as a molecular adjuvant: bridging innate and acquired immunity","volume":"271","author":"Dempsey","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.molimm.2010.12.019_bib0125","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.4049\/jimmunol.160.11.5273","article-title":"Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response","volume":"160","author":"Fang","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0130","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.18.1.393","article-title":"Regulation of B lymphocyte responses to foreign and self-antigens by the CD19\/CD21 complex","volume":"18","author":"Fearon","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0135","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.4049\/jimmunol.144.9.3458","article-title":"Comparative structure and evolution of murine CR2. The homolog of the human C3d\/EBV receptor (CD21)","volume":"144","author":"Fingeroth","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0140","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1073\/pnas.86.1.242","article-title":"Identification of murine complement receptor type 2","volume":"86","author":"Fingeroth","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.molimm.2010.12.019_bib0145","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1073\/pnas.81.14.4510","article-title":"Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2","volume":"81","author":"Fingeroth","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2010.12.019_bib0150","doi-asserted-by":"crossref","first-page":"865","DOI":"10.4049\/jimmunol.146.3.865","article-title":"Expression of CR2 (the C3dg\/EBV receptor, CD21) on normal human peripheral blood T lymphocytes","volume":"146","author":"Fischer","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0155","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.4049\/jimmunol.169.4.2126","article-title":"Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire","volume":"169","author":"Fleming","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0160","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/eji.1830260714","article-title":"Human lymphocytes shed a soluble form of CD21 (the C3dg\/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23","volume":"26","author":"Fremeaux-Bacchi","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0165","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1016\/S0021-9258(18)94149-9","article-title":"Genomic organization and polymorphisms of the human C3d\/Epstein-Barr virus receptor","volume":"264","author":"Fujisaku","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2010.12.019_bib0170","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1084\/jem.20042239","article-title":"Complement receptors regulate differentiation of bone marrow plasma cell precursors expressing transcription factors Blimp-1 and XBP-1","volume":"201","author":"Gatto","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2010.12.019_bib0175","doi-asserted-by":"crossref","first-page":"5758","DOI":"10.4049\/jimmunol.167.10.5758","article-title":"Epitope mapping using the X-ray crystallographic structure of complement receptor type 2 (CR2\/CD21): identification of a highly inhibitory monoclonal antibody that directly recognizes the CR2-C3d interface","volume":"167","author":"Guthridge","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0180","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.immuni.2005.04.011","article-title":"B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae","volume":"23","author":"Haas","year":"2005","journal-title":"Immunity."},{"key":"10.1016\/j.molimm.2010.12.019_bib0185","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.imlet.2006.01.002","article-title":"CD5+\/Mac-1-peritoneal B cells: a novel B cell subset that exhibits characteristics of B-1 cells","volume":"105","author":"Hastings","year":"2006","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.molimm.2010.12.019_bib0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0022-1759(01)00471-9","article-title":"Generation of recombinant human C3dg tetramers for the analysis of CD21 binding and function","volume":"258","author":"Henson","year":"2001","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/j.molimm.2010.12.019_bib0195","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1182\/blood.V95.8.2617","article-title":"Tracing uptake of C3dg-conjugated antigen into B cells via complement receptor type 2 (CR2, CD21)","volume":"95","author":"Hess","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2010.12.019_bib0200","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0022-1759(84)90150-9","article-title":"An enzyme linked immunosorbent assay for measuring anti-sheep erythrocyte antibodies","volume":"68","author":"Heyman","year":"1984","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2010.12.019_bib0205","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1084\/jem.172.2.665","article-title":"In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody","volume":"172","author":"Heyman","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2010.12.019_bib0210","doi-asserted-by":"crossref","first-page":"6968","DOI":"10.4049\/jimmunol.178.11.6968","article-title":"Role for CD21 in the establishment of an extracellular HIV reservoir in lymphoid tissues","volume":"178","author":"Ho","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0215","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.molimm.2007.12.015","article-title":"Modulation of murine complement receptor type 2 (CR2\/CD21) ectodomain shedding by its cytoplasmic domain","volume":"45","author":"Hoefer","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0220","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.molimm.2006.07.003","article-title":"Complement receptor 2, natural antibodies and innate immunity: inter-relationships in B cell selection and activation","volume":"44","author":"Holers","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0225","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.4049\/jimmunol.177.4.2056","article-title":"Cutting edge: Epstein-Barr virus transactivates the HERV-K18 superantigen by docking to the human complement receptor 2 (CD21) on primary B cells","volume":"177","author":"Hsiao","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0230","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.4049\/jimmunol.181.5.2953","article-title":"Comparative functional evolution of human and mouse CR1 and CR2","volume":"181","author":"Jacobson","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0235","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.4049\/jimmunol.180.7.5057","article-title":"Complement receptors 1 and 2 influence the immune environment in a B cell receptor-independent manner","volume":"180","author":"Jacobson","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0240","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.TP.0000101008.13282.FD","article-title":"The role of complement receptors in production of antibodies specific for Galalpha1,3Gal","volume":"77","author":"Kaye","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.molimm.2010.12.019_bib0245","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.4049\/jimmunol.160.4.1565","article-title":"Cross-linking CD21\/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells","volume":"160","author":"Kozono","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0250","doi-asserted-by":"crossref","first-page":"2808","DOI":"10.1016\/j.molimm.2008.01.036","article-title":"Complement receptor CR2\/CR1 deficiency protects mice from collagen-induced arthritis and associates with reduced autoantibodies to type II collagen and citrullinated antigens","volume":"45","author":"Kuhn","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0255","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/eji.200636248","article-title":"Intrinsic B cell hypo-responsiveness in mice prematurely expressing human CR2\/CD21 during B cell development","volume":"37","author":"Kulik","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0260","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.4049\/jimmunol.144.9.3581","article-title":"The murine complement receptor gene family. IV. Alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1","volume":"144","author":"Kurtz","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0265","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.4049\/jimmunol.175.12.8011","article-title":"Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21\/CD19 complex engagement","volume":"175","author":"Lee","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0270","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1002\/eji.200324330","article-title":"Complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) cooperate in the binding of hydrolyzed complement factor 3 (C3i) to human B lymphocytes","volume":"33","author":"Leslie","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0275","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1046\/j.1365-2567.1999.00846.x","article-title":"The influence of complement receptor type 1 (CD35) and decay-accelerating factor (CD55) on complement receptor type 2-(CD21) mediated alternative pathway activation by B cells","volume":"97","author":"Leslie","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2010.12.019_bib0280","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1111\/j.1365-2567.2009.03056.x","article-title":"Spontaneous complement activation on human B cells results in localized membrane depolarization and the clustering of complement receptor type 2 and C3 fragments","volume":"128","author":"Lobner","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2010.12.019_bib0285","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.cellsig.2005.10.001","article-title":"Activation of Epstein-Barr virus\/C3d receptor (gp140, CR2, CD21) on human B lymphoma cell surface triggers Cbl tyrosine phosphorylation, its association with p85 subunit, Crk-L and Syk and its dissociation with Vav","volume":"18","author":"Lottin-Divoux","year":"2006","journal-title":"Cell Signal."},{"key":"10.1016\/j.molimm.2010.12.019_bib0290","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.4049\/jimmunol.153.10.4448","article-title":"Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV","volume":"153","author":"Luxembourg","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0295","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.4049\/jimmunol.174.6.3264","article-title":"Co-ligation of the B cell receptor with complement receptor type 2 (CR2\/CD21) using its natural ligand C3dg: activation without engagement of an inhibitory signaling pathway","volume":"174","author":"Lyubchenko","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0300","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.4049\/jimmunol.179.5.2695","article-title":"Cutting edge: Complement (C3d)-linked antigens break B cell anergy","volume":"179","author":"Lyubchenko","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0305","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.4049\/jimmunol.177.8.5155","article-title":"A novel mechanism for complement activation at the surface of B cells following antigen binding","volume":"177","author":"Manderson","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0310","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.4049\/jimmunol.169.7.3526","article-title":"Expression of human complement receptor type 2 (CR2\/CD21) in mice during early B cell development results in a reduction in mature B cells and hypogammaglobulinemia","volume":"169","author":"Marchbank","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0315","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.4049\/jimmunol.165.5.2354","article-title":"Expression of human complement receptor 2 (CR2\/CD21) in Cr2\u2212\/\u2212 mice restores humoral immune function","volume":"165","author":"Marchbank","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0320","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1002\/eji.200323843","article-title":"B cell activation leads to shedding of complement receptor type II (CR2\/CD21)","volume":"33","author":"Masilamani","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0325","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.4049\/jimmunol.145.9.2974","article-title":"A molecular and immunochemical characterization of mouse CR2: evidence for a single gene model of mouse Complement Receptors 1 and 2","volume":"145","author":"Molina","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0330","doi-asserted-by":"crossref","first-page":"789","DOI":"10.4049\/jimmunol.153.2.789","article-title":"Analysis of C3b\/C3d binding sites and factor I cofactor regions within mouse complement receptors 1 and 2","volume":"153","author":"Molina","year":"1994","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0335","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.imlet.2007.12.007","article-title":"Novel roles for murine complement receptors type 1 and 2 I. Regulation of B cell survival and proliferation by CR1\/2","volume":"116","author":"Molnar","year":"2008","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.molimm.2010.12.019_bib0340","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.imlet.2007.12.010","article-title":"Novel roles for murine complement receptors type 1 and 2 II. Expression and function of CR1\/2 on murine mesenteric lymph node T cells","volume":"116","author":"Molnar","year":"2008","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.molimm.2010.12.019_bib0345","doi-asserted-by":"crossref","first-page":"9194","DOI":"10.1073\/pnas.84.24.9194","article-title":"Molecular cloning of the cDNA encoding the Epstein-Barr virus\/C3d receptor (complement receptor type 2) of human B lymphocytes","volume":"84","author":"Moore","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.molimm.2010.12.019_bib0350","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1128\/JVI.55.2.347-351.1985","article-title":"Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2)","volume":"55","author":"Nemerow","year":"1985","journal-title":"J. Virol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0355","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1046\/j.1365-2567.2001.01325.x","article-title":"CR2-mediated activation of the complement alternative pathway results in formation of membrane attack complexes on human B lymphocytes","volume":"104","author":"Nielsen","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2010.12.019_bib0360","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1046\/j.1365-2567.1997.00138.x","article-title":"The role of complement receptor type 1 (CR1, CD35) in determining the cellular distribution of opsonized immune complexes between whole blood cells: kinetic analysis of the buffering capacity of erythrocytes","volume":"90","author":"Nielsen","year":"1997","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2010.12.019_bib0365","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/ni1494","article-title":"Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells","volume":"8","author":"Phan","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0370","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3109\/08830180109045588","article-title":"CD19, CD21, and CD22: multifaceted response regulators of B lymphocyte signal transduction","volume":"20","author":"Poe","year":"2001","journal-title":"Intl. Rev. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0375","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4049\/jimmunol.170.1.84","article-title":"Impaired antibody response to group B streptococcal type III capsular polysaccharide in C3- and complement receptor 2-deficient mice","volume":"170","author":"Pozdnyakova","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0380","first-page":"338","article-title":"A critical role of complement in regulation of self-reactive B cells","volume":"35","author":"Prodeus","year":"1998","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0385","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1074-7613(00)80669-X","article-title":"A critical role for complement in maintenance of self-tolerance","volume":"9","author":"Prodeus","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.molimm.2010.12.019_bib0390","doi-asserted-by":"crossref","first-page":"5433","DOI":"10.4049\/jimmunol.169.10.5433","article-title":"Functional activity of natural antibody is altered in Cr2-deficient mice","volume":"169","author":"Reid","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0395","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0065-2776(08)60341-7","article-title":"Membrane complement receptors specific for bound fragments of C3","volume":"37","author":"Ross","year":"1985","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0400","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.4049\/jimmunol.168.9.4257","article-title":"Cutting edge commentary: two B-1 or not to be one","volume":"168","author":"Rothstein","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0405","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.virol.2006.04.018","article-title":"T cell-independent and T cell-dependent immunoglobulin G responses to polyomavirus infection are impaired in complement receptor 2-deficient mice","volume":"352","author":"Szomolanyi-Tsuda","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.molimm.2010.12.019_bib0410","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.4049\/jimmunol.159.3.1557","article-title":"Mouse complement receptors type 1 (CR1; CD35) and type 2 (CR2; CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL\/lpr mice","volume":"159","author":"Takahashi","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0415","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0167-5699(94)90274-7","article-title":"The CD19\/CD21 signal transduction complex of B lymphocytes","volume":"15","author":"Tedder","year":"1994","journal-title":"Immunol. Today"},{"key":"10.1016\/j.molimm.2010.12.019_bib0420","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.molimm.2006.10.014","article-title":"Internalization and molecular interactions of human CD21 receptor","volume":"44","author":"Tessier","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0425","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1365-2249.1996.57761.x","volume":"104","author":"Thornton","year":"1996","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0430","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0952-7915(99)80041-7","article-title":"Co-receptors on B lymphocytes","volume":"11","author":"Tsubata","year":"1999","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0435","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1084\/jem.173.5.1083","article-title":"Molecular interactions of complement receptors on B lymphocytes: a CR1\/CR2 complex distinct from the CR2\/CD19 complex","volume":"173","author":"Tuveson","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.molimm.2010.12.019_bib0440","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.1016\/j.molimm.2007.02.011","article-title":"Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3","volume":"44","author":"Twohig","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0445","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0022-1759(86)90506-5","article-title":"Purification of the B lymphocyte receptor for the C3d fragment of complement and the Epstein-Barr virus by monoclonal antibody affinity chromatography, and assessment of its functional capacities","volume":"92","author":"Weis","year":"1986","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2010.12.019_bib0450","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.molimm.2006.02.032","article-title":"Low doses of antigen coupled to anti-CR2 mAbs induce rapid and enduring IgG immune responses in mice and in cynomolgus monkeys","volume":"44","author":"Whipple","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2010.12.019_bib0455","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.4049\/jimmunol.165.6.3119","article-title":"Impaired affinity maturation in Cr2\u2212\/\u2212 mice is rescued by adjuvants without improvement in germinal center development","volume":"165","author":"Wu","year":"2000","journal-title":"J. Immunol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589011000113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589011000113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:12:59Z","timestamp":1685923979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589011000113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3]]},"references-count":91,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0161589011000113"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2010.12.019","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2011,3]]}}}